Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
12.04. | Lady Gaga's Instagram post about latest Pfizer Nurtec ODT ad earns EU ire: Politico | ||
12.04. | Eisai on your hi-fi: Leqembi maker supports creation of Alzheimer's podcast miniseries | ||
12.04. | EU regulator finds no link between GLP-1s and suicidal thoughts | ||
12.04. | With 9% pay hike, Merck CEO Davis entered $20M compensation club in 2023 | ||
12.04. | Shareholders approve AstraZeneca's 2024 pay proposal for CEO Pascal Soriot despite proxy adviser discontent | ||
11.04. | 89bio lines up China CDMO to build API plant for commercial production of MASH candidate | ||
11.04. | Fujifilm Diosynth blueprints another $1.2B expansion at North Carolina plant where it aims to employ 1,400 | ||
11.04. | Castle Biosciences fortifies support of Esophageal Cancer Awareness Month with fundraising, educational collabs | ||
11.04. | Regeneron hit with DOJ complaint that it hid 'hundreds of millions' in Eylea credit card processing fees from Medicare | ||
11.04. | Pfizer settles 12-year-old lawsuit in alleged pay-for-delay scheme for $39M | ||
11.04. | Facing uncertain vaccine demand, Moderna halts mRNA plant buildout in Kenya | ||
11.04. | Number of ongoing US drug shortages reaches new high, pharmacist group says | ||
10.04. | BIO's lobbying chief departs against backdrop of China-US biosecurity concerns, drug-price reckoning | ||
10.04. | API Innovation Center looks to bolster US cancer drug supplies with Apertus deal, new tech | ||
10.04. | Leading AstraZeneca investor defends CEO pay ahead of shareholder vote: FT | ||
10.04. | Novartis halts recruitment of Kisqali trials as it adjusts production methods | ||
10.04. | FDA appears receptive to surrogate endpoint supporting accelerated approval of multiple myeloma drugs | ||
10.04. | Lady Gaga goes behind the camera in 'next chapter' of Nurtec ODT campaign with Pfizer | ||
10.04. | FDA lambasts Kilitch for unsanitary manufacturing conditions and issues warning letter to Natco, too | ||
09.04. | Amid corporate restructuring, Novartis plots 680 layoffs in development group | ||
09.04. | Perrigo pairs Opill OTC birth control med with WNBA in multiyear team-up | ||
09.04. | CG Life adds Toolhouse to portfolio, snapping up digital agency to double in size | ||
09.04. | AACR: Detailed data spark glimmer of hope for Merck's Keytruda-Lynparza combo in lung cancer | ||
09.04. | Bayer taps new North America marketing chief for consumer health division | ||
09.04. | Advanced therapy CDMO Ascend nabs Florida manufacturing site and team from ocular gene therapy outfit Beacon |